Obeticholic acid for severe bile acid diarrhea with intestinal failure: A case report and review of the literature. (Q55345479)

3 July 2018

4 references

23 March 2019

21 March 2019

13 November 2019

12 November 2020

0 references

Obeticholic acid for severe bile acid diarrhea with intestinal failure: A case report and review of the literature. (English)

1 reference

3 July 2018

4 references

23 March 2019

21 March 2019

13 November 2019

12 November 2020

4 references

23 March 2019

21 March 2019

13 November 2019

12 November 2020

1 reference

13 November 2019

gastrointestinal agent

1 reference

12 November 2020

Christian Lodberg Hvas

1

1 reference

3 July 2018

Peter Ott

2

1 reference

3 July 2018

Peter Paine

3

1 reference

3 July 2018

Simon Lal

4

1 reference

3 July 2018

Søren Peter Jørgensen

5

1 reference

3 July 2018

Jens Frederik Dahlerup

6

1 reference

3 July 2018

language of work or name

English

0 references

publication date

1 June 2018

1 reference

3 July 2018

World Journal of Gastroenterology

7 June 2018

4 references

23 March 2019

21 March 2019

13 November 2019

12 November 2020

5 references

3 July 2018

23 March 2019

21 March 2019

13 November 2019

12 November 2020

24

1 reference

3 July 2018

page(s)

2320-2326

1 reference

3 July 2018

issue

21

1 reference

3 July 2018

Creative Commons Attribution-NonCommercial 4.0 International

copyright license

4 references

23 March 2019

21 March 2019

13 November 2019

on focus list of Wikimedia project

12 November 2020

ScienceSource

0 references

cites work

Long-term effect of medical treatment of diarrhoea in 594 patients with SeHCAT scan diagnosed bile acid malabsorption from 2003 to 2016; a retrospective study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5989246

How bad is bile acid diarrhoea: an online survey of patient-reported symptoms and outcomes

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5989246

Secretory diarrhoea: mechanisms and emerging therapies

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5989246

Bile Acid diarrhea: prevalence, pathogenesis, and therapy

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5989246

Diarrhea in Crohn’s disease: investigating the role of the ileal hormone fibroblast growth factor 19.

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5989246

Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid.

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5989246

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5989246

The response of patients with bile acid diarrhoea to the farnesoid X receptor agonist obeticholic acid.

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5989246

ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults.

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5989246

Bile acid malabsorption in inflammatory bowel disease

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5989246

Bile acid diarrhoea and FGF19: new views on diagnosis, pathogenesis and therapy

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5989246

Systematic review: the management of chronic diarrhoea due to bile acid malabsorption.

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5989246

SeHCAT [tauroselcholic (selenium-75) acid] for the investigation of bile acid malabsorption and measurement of bile acid pool loss: a systematic review and cost-effectiveness analysis

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5989246

Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5989246

Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5989246

Fibroblast growth factor 19 serum levels: relation to renal function and metabolic parameters

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5989246

Chronic diarrhea due to excessive bile acid synthesis and not defective ileal transport: a new syndrome of defective fibroblast growth factor 19 release

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5989246

A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5989246

Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5989246

A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5989246

Characterizing Factors Associated With Differences in FGF19 Blood Levels and Synthesis in Patients With Primary Bile Acid Diarrhea.

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5989246

Pronounced variation in bile acid synthesis in humans is related to gender, hypertriglyceridaemia and circulating levels of fibroblast growth factor 19.

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5989246

Bile acid malabsorption in patients with chronic diarrhoea: clinical value of SeHCAT test

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5989246

Quantifying bile acid malabsorption helps predict response and tailor sequestrant therapy

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5989246

Bile acid malabsorption investigated by selenium-75-homocholic acid taurine ((75)SeHCAT) scans: causes and treatment responses to cholestyramine in 298 patients with chronic watery diarrhoea

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5989246

Studies of the prevalence and significance of radiolabeled bile acid malabsorption in a group of patients with idiopathic chronic diarrhea

2 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29881241

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Irritable Bowel Syndrome

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29881241

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3748/WJG.V24.I21.2320

1 reference

3 July 2018

PMCID

5989246

1 reference

3 July 2018

PubMed ID

29881241

1 reference

3 July 2018